4//SEC Filing
Hulihan Joseph 4
Accession 0001415889-24-020895
CIK 0001267813other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:05 PM ET
Size
5.7 KB
Accession
0001415889-24-020895
Insider Transaction Report
Form 4
Hulihan Joseph
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2024-08-05$1.13/sh−4,828$5,456→ 72,725 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on May 16, 2022 to cover tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.15, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Documents
Issuer
MARINUS PHARMACEUTICALS, INC.
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001794018
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:05 PM ET
- Size
- 5.7 KB